Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34